AID-912

N/A

Report date: 2025/07/03 16:42:43

Base Information

Drug NameAID-912
Drug Alias NameAID-912
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionT lymphocyte replacements
TargetsNot applicable
Therapy Area/IndicationsScleroderma, Systemic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCoya Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCoya Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsScleroderma, Systemic

Other Information

ATC CodeN/A
Related LinksN/A